secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001396814-24-000124
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pacira names Lauren Riker interim CFO; Reinhart departs Sept 30
---------------------------------------------------------------

- CFO Charles Reinhart departs Sept 30, 2024; will serve as consultant for 9 months.
- Lauren Riker, SVP of Finance, appointed interim CFO effective Oct 1, 2024.
- Riker's base salary unchanged at $374,700; bonus target 50%; receives one-time $75k bonus.
- Riker to serve as interim CFO until permanent successor identified.
- No changes to existing employment agreement or other compensation terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000139681424000124/0001396814-24-000124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000139681424000124/pcrx-20240926.htm
  HTML page:      https://secwatch.observer/filing/0001396814-24-000124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer